Training activity information

Details

Interpret testing results for a patient with an incompatible living kidney donor and outline the transplant options for the patient

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

  • Relevant patient factors impacting options
  • Local policy and national guidelines
  • Strategies to improve access to transplantation for sensitised patients
  • UKLKSS
  • ODT tools
  • Legislation for living donor transplantation
  • Pre and post desensitisation antibody monitoring
  • Implications for crossmatch testing

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

  • What is the aim of interpreting these results and outlining transplant options?
  • How does this contribute to finding the best possible outcome for the patient and their donor?
  • What is your current understanding of ABO and HLA incompatibility in living kidney transplantation?
  • Are you familiar with different strategies to overcome these incompatibilities (e.g., desensitisation protocols, paired kidney donation)?
  • What factors need to be considered when outlining transplant options?
  • What specific skills in interpreting complex immunological data in the context of living donor incompatibility do you hope to gain?
  • How will you learn to evaluate and present the different transplant options available to the patient?
  • What are the ethical considerations involved in these situations that you want to explore further? What level of complexity do you expect in interpreting the results?
  • What information about the patient and donor will you need to review beforehand (e.g., HLA typing, antibody profiles, medical history)?
  • Will you research different desensitization protocols and kidney sharing schemes?
  • Will you discuss potential options and reporting strategies with your supervisor? How do you feel about the challenges of navigating incompatible transplants?

In action

  • What specific testing results are you currently analysing (e.g., HLA typing, antibody screening, crossmatch results)?
  • What are the key incompatibilities you are identifying between the patient and the living donor?
  • How are you evaluating the significance of these incompatibilities in the context of transplantation?
  • What potential transplant options are you actively considering based on the test results?
  • What information are you prioritising to formulate a clear outline of these options?
  • Are you finding it straightforward to identify the incompatibilities and their potential implications?
  • How effective are you at recalling or accessing information about different desensitisation protocols or alternative transplant strategies?
  • What challenges are you facing in translating the technical results into understandable transplant options for the patient (or the team)?
  • What are you learning about the complexities of incompatible living donor kidney transplantation as you interpret these results?
  • If the testing results are complex or present multiple incompatibilities, how are you organising your analysis?
  • Are you considering the limitations of the testing methods or the potential for further investigation?
  • What additional information might you need to formulate a comprehensive set of transplant options?
  • Are you ensuring your interpretation and proposed options align with current best practices and local protocols for incompatible transplants?

On action

  • What specific incompatibilities were identified in the testing results?
    • What different transplant options were available for this patient despite the incompatibility?
    • What were the key considerations and potential challenges associated with each option?
    • How did the testing results guide the outlining of these options?
  • What are the various strategies and approaches to overcome HLA and/or ABO incompatibility in living donor kidney transplantation?
    • How do different testing methodologies contribute to identifying and characterising incompatibilities?
    • What factors need to be considered when discussing transplant options with patients and the clinical team in incompatible situations?
    • Did this activity improve your understanding of the complexities of incompatible living donor transplantation?
  • How will you approach the interpretation of results in future incompatible living donor cases?
    • What further information do you need to learn about the different desensitisation protocols and transplant strategies?
    • How will you communicate these complex issues clearly and effectively?

Beyond action

  • Have you reviewed the specific testing results and the transplant options you outlined for the patient with an incompatible living kidney donor?
  • Have you considered any alternative interpretations of the results or additional transplant options that might exist based on subsequent learning?
  • Did discussing this case with your supervisor or colleagues provide new perspectives or insights that have led you to re-evaluate your initial assessment?
  • Has this training activity enhanced your understanding of the complexities of incompatible living donor transplantation, including the immunological challenges and available strategies?
  • How has this experience influenced your approach to interpreting complex histocompatibility data in other contexts?
  • Has it improved your ability to consider and communicate various clinical options based on laboratory findings?
  • How has this training activity developed your ability to interpret and report tests across a range of techniques applied and provide appropriate clinical advice for solid organ transplant?
  • Will the knowledge gained from this activity be beneficial in future discussions with clinical teams or when considering options for highly sensitised patients?
  • What further learning or experience in the area of incompatible transplantation would you like to pursue based on this training activity?

Relevant learning outcomes

# Outcome
# 2 Outcome

Interpret and report tests across the range of techniques applied and provide appropriate clinical advice for solid organ transplant.

# 3 Outcome

Assess the suitability of patients for crossmatch and transplantation in deceased and live donor settings.

# 7 Outcome

Practice in accordance with quality management and accreditation standards.

# 8 Outcome

Practice effectively in partnership with service users, other clinical specialisms and the wider multidisciplinary team in the investigation of solid organ transplantation and platelet transfusion.